Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

H. Hjorth-Hansen, J. Stentoft, J. Richter, P. Koskenvesa, M. Höglund, A. Dreimane, K. Porkka, T. Gedde-Dahl, B. T. Gjertsen, F. X. Gruber, L. Stenke, K. M. Eriksson, B. Markevärn, A. Lübking, H. Vestergaard, L. Udby, O. W. Bjerrum, I. Persson, S. Mustjoki, U. Olsson-Strömberg

Research output: Contribution to journalArticlepeer-review

44 Citations (SciVal)

Fingerprint

Dive into the research topics of 'Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients'. Together they form a unique fingerprint.

Medicine & Life Sciences